Supernus Pharmaceuticals, Inc.
SUPN
$50.53
$1.162.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 384.24M | 308.67M | 281.16M | 522.60M | 463.59M |
| Total Receivables | 182.18M | 187.80M | 171.25M | 140.83M | 145.64M |
| Inventory | 87.06M | 82.39M | 79.40M | 44.02M | 49.42M |
| Prepaid Expenses | 78.09M | 65.33M | 62.08M | 31.42M | 28.93M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 731.58M | 644.18M | 593.89M | 738.87M | 687.58M |
|
|
|||||
| Total Current Assets | 731.58M | 644.18M | 593.89M | 738.87M | 687.58M |
| Net Property, Plant & Equipment | 36.44M | 37.24M | 39.39M | 32.95M | 34.06M |
| Long-term Investments | 120.67M | 124.88M | 119.08M | 117.02M | 117.02M |
| Goodwill | 120.67M | 124.88M | 119.08M | 117.02M | 117.02M |
| Total Other Intangibles | 549.71M | 569.46M | 623.48M | 481.31M | 502.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.33M | 76.89M | 43.91M | 12.26M | 6.50M |
| Total Assets | 1.50B | 1.45B | 1.42B | 1.38B | 1.35B |
|
|
|||||
| Total Accounts Payable | 10.17M | 2.68M | 8.18M | 8.22M | 7.07M |
| Total Accrued Expenses | 232.93M | 217.81M | 230.84M | 197.03M | 184.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.64M | 10.61M | 10.79M | 7.39M | 5.94M |
| Total Finance Division Other Current Liabilities | 120.19M | 107.07M | 80.83M | 73.73M | 84.67M |
| Total Other Current Liabilities | 120.19M | 107.07M | 80.83M | 73.73M | 84.67M |
| Total Current Liabilities | 373.93M | 338.17M | 330.63M | 286.36M | 281.77M |
|
|
|||||
| Total Current Liabilities | 373.93M | 338.17M | 330.63M | 286.36M | 281.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.27M | 30.37M | 31.42M | 24.38M | 26.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.72M | 22.40M | 8.04M | 7.76M | 8.45M |
| Total Liabilities | 423.92M | 390.93M | 370.09M | 318.51M | 316.59M |
|
|
|||||
| Common Stock & APIC | 561.48M | 543.88M | 527.76M | 497.00M | 486.27M |
| Retained Earnings | 515.58M | 517.88M | 521.98M | 567.10M | 544.60M |
| Treasury Stock & Other | -255.00K | -44.00K | -71.00K | -200.00K | -159.00K |
| Total Common Equity | 1.08B | 1.06B | 1.05B | 1.06B | 1.03B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.08B | 1.06B | 1.05B | 1.06B | 1.03B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.08B | 1.06B | 1.05B | 1.06B | 1.03B |
|
|
|||||